Janssen Alzheimer Immunotherapy
United States of America (USA)
1 December 2019 - 30 November 2020
Principal institution: Johnson & Johnson
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Janssen Alzheimer Immunotherapy published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 2 | 0.01 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 2 | 0.01 | |
Top articles by Altmetric score in current window
Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease
Nature Communications
2020-05-26
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
Nature Communications
2020-01-17
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
